Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk

NCT: NCT05619003 · COMPLETED

NCT IDNCT05619003
StatusCOMPLETED
Start Date2022-08-15
Completion2022-12-08

Brief Summary

A post market clinical follow-up study investigating the safety of Biatain Silicone Sacral while used as prevention in hospital admitted patients at risk of developing a pressure injury.

Frequently Asked Questions

What is Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk?

Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk is a clinical trial registered under NCT05619003. Current status: COMPLETED.

What is the status of NCT05619003?

The current status of NCT05619003 (Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk) is: COMPLETED.

When did Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk start?

Biatain Silicone Sacral for Pressure Injury Prevention in Hospital-admitted Patients at Risk started on 2022-08-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑